BrainTrip | Expo 2020 Dubai

1 October 2021 – 31 March 2022

Suggestions

Select a language

Select Currency

Currencies excluding AED are indicative only.

If you would like to view prices in another currency, change it from the menu.

Creating affordable screening tools for dementia

Problem

Dementia affects more than 50 million people worldwide, with only a tiny fraction diagnosed and receiving care.

Solution

A fast and affordable way to screen for dementia, enabling early treatment.

Sector

Origin

Presence

About the company

BrainTrip proposes a novel approach for early, fast, and affordable dementia screening based on electroencephalography (EEG). BrainTrip has developed, scientifically tested, and validated the BrainTrip Cognitive Index (BCI), an algorithm for the reliable detection of cognitive impairment, which can be the result of early-stage dementia. Our product is a piece of software compatible with existing, inexpensive, and portable EEG devices that we source and supply to hospitals, nursing homes, and other health practitioners. The test is based on brainwave analysis and enables early dementia detection, which leads to early treatment.